跳至主要内容
临床试验/NCT01928901
NCT01928901已完成2 期

Randomized, Placebo-controlled, Double-blind, Cross-over Trial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)

Bionorica SE1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
Bionorica SE
入组人数
56
试验地点
1
主要终点
Time to perception of sweetness

研究概览

简要总结

Proof of concept: Superiority of Bronchipret or Sinupret to placebo in respect to mucociliary clearance

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
25 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Volunteers who have given their signed declaration of consent and have signed the data protection declaration
  • Male or female volunteers 25 - 40 years
  • Current smokers (5-20 cigarettes per day since 5 years at least)
  • Ability to taste sweetness of saccharin
  • Perception of sweetness within 30 minutes after placement of saccharin behind nasal valve

排除标准

  • Ciliary dyskinesia
  • Cystic fibrosis
  • COPD/emphysema
  • Chronic rhinosinusitis
  • Acute respiratory tract infection within the last 6 weeks prior to enrolment
  • Septal or sinus surgery
  • Symptomatic allergic rhinitis
  • Known allergic rhinitis
  • Treatment with not-permitted previous or concomitant therapy
  • History of snuff consumption for longer than 1 month or intranasal consumption of recreational drugs such as cocaine or heroin for longer than 1 month
  • Any disease or condition that might affect the safety of the subject during the trial, according to the investigator's judgement

研究组 & 干预措施

administration of Bronchipret

Experimental

7 days of administration of Bronchipret, 2 FCT t.i.d

干预措施: administration of Bronchipret (Drug)

administration of Bronchipret

Experimental

7 days of administration of Bronchipret, 2 FCT t.i.d

干预措施: administration of Bronchipret Placebo (Drug)

administration of Sinupret

Experimental

7 days of administration of Sinupret, 2 CT t.i.d

干预措施: administration of Sinupret (Drug)

administration of Sinupret

Experimental

7 days of administration of Sinupret, 2 CT t.i.d

干预措施: administration of Sinupret Placebo (Drug)

administration of Bronchipret Placebo

Placebo Comparator

7 days of administration of Bronchipret Placebo, 2 FCT t.i.d

干预措施: administration of Bronchipret (Drug)

administration of Bronchipret Placebo

Placebo Comparator

7 days of administration of Bronchipret Placebo, 2 FCT t.i.d

干预措施: administration of Bronchipret Placebo (Drug)

administration of Sinupret Placebo

Placebo Comparator

7 days of administration of Sinupret Placebo, 2 CT t.i.d

干预措施: administration of Sinupret (Drug)

administration of Sinupret Placebo

Placebo Comparator

7 days of administration of Sinupret Placebo, 2 CT t.i.d

干预措施: administration of Sinupret Placebo (Drug)

结局指标

主要结局

Time to perception of sweetness

时间窗: after 7 days of treatment

Time to perception of sweetness after 7 days of treatment with the investigational products - relative to the time to perception of sweetness at the begin-ning of treatment

次要结局

  • Perception of Sweetness of Saccharin(4 - 7 weeks)

研究者

发起方
Bionorica SE
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验